Mauro Aparecido de Sousa Xavier

Mauro Aparecido de Sousa Xavier

Auto-generated profile, based on publicly available information

Mauro Aparecido de Sousa Xavier

UNIMONTES- Universidade Estadual de Montes Claros

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
GTGuilherme G. Trindade
Guilherme G. Trindade
SCSamyra M.C. Caxito
Samyra M.C. Caxito
AXAlessandra Rejane E.O. Xavier
Alessandra Rejane E.O. Xavier
MXMauro A.S. Xavier
Mauro A.S. Xavier
FBFabiana Brandao
Fabiana Brandao
COVID-19 emerged in December 2019 in China, and since then, has disrupted global public health and changed economic paradigms. In dealing with the new Coronavirus, SARS-CoV-2, the world has not faced such extreme global fragility since the "Spanish flu" pandemic in 1918. Researchers globally are dedicating efforts to the search for an effective treatment for COVID-19. Drugs already used in a clinical setting for other pathologies have been tested as a new therapeutic approach against SARS-CoV-2, setting off a frenzy over the preliminary data of different studies. This work aims to compile and discuss the data published thus far. Despite the potential effects of some antivirals and antiparasitic against COVID-19, clinical studies must confirm real effectiveness. However, non-pharmacological approaches have proven to be the most efficient strategy to date.

2 December 2019 in Veterinary World
Verified
Journal Article
Open access
GSGeziella Áurea Aparecida Damasceno Souza
Geziella Áurea Aparecida Damasceno Souza
AAAnna Christina de Almeida
Anna Christina de Almeida
MXMauro Aparecido de Sousa Xavier
Mauro Aparecido de Sousa Xavier
LSLívia Mara Vitorino da Silva
Lívia Mara Vitorino da Silva
CSCintya Neves Sousa
Cintya Neves Sousa
AXAlessandra Rejane Ericsson de Oliveira Xavier
Alessandra Rejane Ericsson de Oliveira Xavier
Background and Aim: The term ESKAPE, recognized by the WHO, is an acronym, which refers to the pathogens Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp., which is extremely virulent and multidrug-resistant. Although the term is used to designate nosocomial pathogens, in a milking environment, strains of Methicillin-resistant S. aureus have been isolated from cattle diagnosed with clinical and subclinical mastitis. Resistant strains may be involved in the transfer of genes conferring resistance to beta-lactam antimicrobials among the species of microorganisms related to mastitis etiology. This study aimed to trace the phenotypic and genotypic profiles of susceptibility to beta-lactams in S. aureus isolated from milk of cattle diagnosed with subclinical mastitis obtained from different rural properties located in the North of Minas Gerais State, Brazil. Materials and Methods: Sixteen microorganisms previously identified as S. aureus isolated from milk of cattle diagnosed with subclinical mastitis were submitted to matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF), mass spectrometry, and polymerase chain reaction (PCR) analysis for microbial species confirmation. The S. aureus beta-lactams antimicrobial phenotypic resistance profile was investigated by disk diffusion method. PCR methods were also performed to investigate the S. aureus genotypic beta-lactams resistance profile. For this purpose, blaZ, mecA, mecALGA251, blaOxa23, and blaKPC genes were screened among S. aureus isolates. The genetic diversity of S. aureus by fingerprint random amplified polymorphic DNA (RAPD)-PCR was also performed in this study. Results: All isolates showed phenotypic resistance to at least three beta-lactams, among which was meropenem. None of the isolates tested positive for the genes mecALGA251, blaOxa23, and blaKPC; however, the presence of the genes blaZ and mecA was detected among the isolates. The fingerprint analysis divided isolates into two distinct groups and 15 different subgroups. Despite the presence of clonality among the isolates, the PCR-RAPD analysis unveiled a heterogeneous profile with genetic diversity among the S. aureus isolates. Conclusion: In this study, we identified beta-lactams resistant S. aureus strains isolated from the milk of cows diagnosed with subclinical mastitis. The S. aureus beta-lactams resistance was investigated using a phenotypic and genotypic approach. We believe that molecular epidemiology, improved knowledge, and genetic basis of resistance to beta-lactams might assist in asserting guidelines for better management practices of dealing with subclinical mastitis and mapping of origin of resistant pathogens in the studied Brazilian area.

1 December 2021 in Anaerobe
Verified
Journal Article
Closed access
RORicardo de Castro Oliveira
Ricardo de Castro Oliveira
CJCarlos Augusto de Oliveira Júnior
Carlos Augusto de Oliveira Júnior
GAGuilherme Guerra Alves
Guilherme Guerra Alves
RARonnie Antunes Assis
Ronnie Antunes Assis
RSRodrigo Otávio Silveira Silva
Rodrigo Otávio Silveira Silva
FLFrancisco Carlos Faria Lobato
Francisco Carlos Faria Lobato

3 November 2020 in Veterinary World
Verified
Journal Article
Open access
NMNatalia Arantes Marcelo
Natalia Arantes Marcelo
VAViviane Aguiar Andrade
Viviane Aguiar Andrade
CSCintya Neves Souza
Cintya Neves Souza
RMRodrigo Pereira Mourão
Rodrigo Pereira Mourão
MMMário Henrique França Mourthe
Mário Henrique França Mourthe
AAAnna Christina Almeida
Anna Christina Almeida
Background and Aim: The use of antimicrobials in the control of mastitis is of concern in public health due to their inefficiency in targeting microorganisms. Studies with medicinal plants have risen as an alternative to the use of conventional products. The objective of this study was to evaluate the efficacy of an experimental disinfectant based on the essential oil (EO) from Lippia origanoides in preventing the development of new intramammary infections (IMI) in Holstein cows. Materials and Methods: The conventional protocol of pre- and post-milking was used and the control (Conventional treatment [CNV]) and experimental (Experimental treatment [PEX]) products containing EO at 120 μL/mL were applied by immersion. Individual milk samples were analyzed using sheep blood agar methodologies and biochemical tests. The efficiency of the treatment was defined by the presence or absence of Staphylococcus aureus, coagulase-negative Staphylococcus, and Streptococcus spp. Results: There were no clinical and subclinical mastitis cases, no lesions in the mucosal of teats, nor dirt score between groups in this study. Both treatments did not influence the occurrence of IMI. Conclusion: The results revealed that PEX acts efficiently against microorganisms compared to the disinfection by the conventional product demonstrating the efficacy of the alternative product on the prevention of new IMIs in dairy cows.

31 August 2024 in Revista Unimontes Científica
Verified
Journal Article
Open access
PDF file
JCJuliana Pimenta Cruz
Juliana Pimenta Cruz
VVViviane De Oliveira Vasconcelos
Viviane De Oliveira Vasconcelos
VRVictor Soares Rodrigues
Victor Soares Rodrigues
OFOtávio Cardoso Filho
Otávio Cardoso Filho
EDEduardo Robson Duarte
Eduardo Robson Duarte
MXMauro Aparecido De Sousa Xavier
Mauro Aparecido De Sousa Xavier
Objetivo: Investigar o uso de extratos vegetais provenientes de plantas presentes no Cerrado como alternativa na controle do carrapato bovino Rhipicephalus microplus. Métodos: O estudo foi conduzido com base em critérios do método PRISMA, com os descritores: “extratos vegetais and Rhipicephalus microplus, “atividade acaricida and extratos vegetais”, “Rhipicephalus microplus and Cerrado”, “acaricidal activity” and “plant extracts” e “Rhipicephalus microplus” and “plant extracts”, selecionando artigos entre 2013 e 2023. Resultados: Foram selecionados 19 estudos que investigaram o potencial das plantas do Cerrado frente a R. microplus. Destes, 18 evidenciaram a eficácia dessas plantas na mortalidade de larvas e fêmeas do carrapato. Indicaram 57 espécies de plantas do Cerrado, pertencentes a 31 famílias botânicas distintas, com a Lauraceae sendo a mais estudada (14%). A maioria dos estudos relatou também uma alta mortalidade nos carrapatos, mesmo com variações nos solventes de extração, sendo o etanol o mais frequente (60,5%), principalmente para extrair folhas (60,5%). Os estudos também priorizaram a avaliação em fêmeas ingurgitadas (93,5%) e, em menor proporção, em larvas (44%). Conclusão: Os estudos sobre plantas do Cerrado no controle de R. microplus são limitados, mas os resultados positivos sugerem potencial para estratégias de controle. No entanto, a falta de estudos sobre os compostos bioativos e sua ação no carrapato indica a necessidade de mais pesquisas para entender melhor o papel dessas plantas no controle dessa ectoparasita e a importância dessas plantas na conservação desse bioma.

1 April 2021 in Brazilian Journal of Development
Verified
Journal Article
Open access
PDF file
NPNayara Gonçalves Pereira
Nayara Gonçalves Pereira
LOLeonardo Ferreira Oliveira
Leonardo Ferreira Oliveira
JOJulia Ortega
Julia Ortega
MVMariana Santana Versiani
Mariana Santana Versiani
AOAlexandre Moisés Ericsson De Oliveira
Alexandre Moisés Ericsson De Oliveira
MXMauro Aparecido de Sousa Xavier
Mauro Aparecido de Sousa Xavier
Introdução: A Bioinformática é o ramo que abrange todas as concepções de aquisição, como: processamento, armazenamento, distribuição, análise e interpretação de informação biológica, embasada na matemática, ciências da computação e na biologia molecular. O presente trabalho consistiu em uma análise teórico-prática baseada em princípios sobre vacinologia, utilizando programas de bioinformática disponíveis, para a construção de uma possível vacina contra Anaplasma marginale, Leishmania spp., SARS-CoV-2 e Clostridium septicum. Metodologia: O desenvolvimento iniciou com a escolha das proteínas de trabalho durante o rastreamento de proteínas viáveis tais como MSP4, Rab, Spike e α-Toxina dos microrganismos supracitados, respectivamente. Utilizando-se de servidores e softwares disponíveis para mapeamento de epitopos de células B e T, estas proteínas foram analisadas para obtenção de epitopos com maior imunogenicidade capazes de estimularem a resposta imune. Resultados: Com as análises realizadas e concluídas, obteve-se várias sequências peptídicas, que foram, a priori, selecionadas as sequências de maiores escores no programa Vaxijen. Conclusões: As sequências escolhidas apresentaram localização acessível na estrutura tridimensional que as caracterizam como bons antígenos e, portanto, a comprovação dos epitopos obtidos deve ser realizada em experimentos in vivo na resposta imune e assim possibilitando o uso destes peptídeos na produção de potenciais vacinas.